Engineering CAR-T cells to remodel cancer cell glycocalyx
Researchers engineered CAR-T cells to display or secrete KLK5 to cleave tumor-associated mucins and improve recognition and killing of cancer cells.
Researchers engineered CAR-T cells to display or secrete KLK5 to cleave tumor-associated mucins and improve recognition and killing of cancer cells.